|
| Quality ImprovementThe quality of the SCT programme is overseen by the Quality Improvement Sub-group, chaired by Jane Woodland. It does this by working in partnership with service users as well as healthcare professionals. The work of this sub group is supported by the quality improvement team. The SCT programme is working with the cross programme QA group to ensure that Quality procedures are joined up across the non cancer screening programmes. Failsafe ProcessesA failsafe is a mechanism to reduce risk. It is the back up mechanism, in addition to usual care which ensures if something goes wrong in the screening pathway, processes are in place to identify the error and correct it before any harm occurs. The NHS Sickle Cell and Thalassaemia Screening Programme's Failsafe Processes document has been produced to provide the public and health care professionals information about the quality of the screening programme. Learning lessonsThe NHS Sickle Cell and Thalassaemia screening programme receives information from different sources on how the screening programme is working across England. The document below outlines in a transparent way how the SCT programme disseminates timely information to local providers so that services can be improved across the country. The audience is screening providers, managers and commissioners at local, sub national and national level. Commissioning FrameworkThe Sickle Cell and Thalassaemia NSC Commissioning Framework is available to download from the UK Screening Portal. This document provides an in-depth description of the commissioning framework for Sickle Cell & Thalassaemia. Please note that this document has been updated to reflect the publication of the Serious Incidents guidance and should be used in preference. |
![]() |